CA2946758C - Microbiological growth media and methods of using the same - Google Patents
Microbiological growth media and methods of using the same Download PDFInfo
- Publication number
- CA2946758C CA2946758C CA2946758A CA2946758A CA2946758C CA 2946758 C CA2946758 C CA 2946758C CA 2946758 A CA2946758 A CA 2946758A CA 2946758 A CA2946758 A CA 2946758A CA 2946758 C CA2946758 C CA 2946758C
- Authority
- CA
- Canada
- Prior art keywords
- composition
- digest
- phosphate buffer
- growth
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 97
- 239000001964 microbiological growth medium Substances 0.000 title abstract description 6
- 239000008363 phosphate buffer Substances 0.000 claims abstract description 68
- 241001465754 Metazoa Species 0.000 claims abstract description 42
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 38
- 244000068988 Glycine max Species 0.000 claims abstract description 37
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 37
- 239000005018 casein Substances 0.000 claims abstract description 37
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 37
- 235000021240 caseins Nutrition 0.000 claims abstract description 37
- 239000012138 yeast extract Substances 0.000 claims abstract description 37
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 36
- 239000008121 dextrose Substances 0.000 claims abstract description 36
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims abstract description 33
- 239000004158 L-cystine Substances 0.000 claims abstract description 33
- 235000019393 L-cystine Nutrition 0.000 claims abstract description 33
- 229960003067 cystine Drugs 0.000 claims abstract description 33
- 229940025294 hemin Drugs 0.000 claims abstract description 29
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 claims abstract description 29
- 239000012528 membrane Substances 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims description 431
- 210000004369 blood Anatomy 0.000 claims description 114
- 239000008280 blood Substances 0.000 claims description 113
- 241001494479 Pecora Species 0.000 claims description 70
- 239000003349 gelling agent Substances 0.000 claims description 59
- 239000004094 surface-active agent Substances 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 239000007788 liquid Substances 0.000 claims description 22
- 239000008213 purified water Substances 0.000 claims description 22
- 239000000499 gel Substances 0.000 claims description 19
- 229920001817 Agar Polymers 0.000 claims description 18
- 239000008272 agar Substances 0.000 claims description 18
- 229920002148 Gellan gum Polymers 0.000 claims description 15
- 229920002907 Guar gum Polymers 0.000 claims description 15
- 239000000645 desinfectant Substances 0.000 claims description 15
- 239000000665 guar gum Substances 0.000 claims description 15
- 235000010417 guar gum Nutrition 0.000 claims description 15
- 229960002154 guar gum Drugs 0.000 claims description 15
- 239000000872 buffer Substances 0.000 claims description 14
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 13
- 239000011734 sodium Substances 0.000 claims description 13
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- 235000010413 sodium alginate Nutrition 0.000 claims description 13
- 239000000661 sodium alginate Substances 0.000 claims description 13
- 229940005550 sodium alginate Drugs 0.000 claims description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- 239000000230 xanthan gum Substances 0.000 claims description 12
- 229920001285 xanthan gum Polymers 0.000 claims description 12
- 235000010493 xanthan gum Nutrition 0.000 claims description 12
- 229940082509 xanthan gum Drugs 0.000 claims description 12
- 239000012736 aqueous medium Substances 0.000 claims description 11
- 229920002401 polyacrylamide Polymers 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 238000004090 dissolution Methods 0.000 claims description 9
- 229920000136 polysorbate Polymers 0.000 claims description 9
- 229950008882 polysorbate Drugs 0.000 claims description 9
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 9
- 241000589291 Acinetobacter Species 0.000 claims description 8
- 241000588722 Escherichia Species 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 7
- 239000008273 gelatin Substances 0.000 claims description 7
- 229920000159 gelatin Polymers 0.000 claims description 7
- 229940014259 gelatin Drugs 0.000 claims description 7
- 235000019322 gelatine Nutrition 0.000 claims description 7
- 235000011852 gelatine desserts Nutrition 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 229920000936 Agarose Polymers 0.000 claims description 6
- 241000186216 Corynebacterium Species 0.000 claims description 6
- 241000589187 Rhizobium sp. Species 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- 241000228212 Aspergillus Species 0.000 claims description 5
- 241000579717 Dermacoccus Species 0.000 claims description 5
- 241000306559 Exserohilum Species 0.000 claims description 5
- 241000579722 Kocuria Species 0.000 claims description 5
- 241000589323 Methylobacterium Species 0.000 claims description 5
- 241000192041 Micrococcus Species 0.000 claims description 5
- 241000179039 Paenibacillus Species 0.000 claims description 5
- 241000228143 Penicillium Species 0.000 claims description 5
- 241000589516 Pseudomonas Species 0.000 claims description 5
- 241000191940 Staphylococcus Species 0.000 claims description 5
- 241000194017 Streptococcus Species 0.000 claims description 5
- 241000187747 Streptomyces Species 0.000 claims description 5
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- 241000186429 Propionibacterium Species 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 239000000787 lecithin Substances 0.000 claims description 4
- 235000010445 lecithin Nutrition 0.000 claims description 4
- 229940067606 lecithin Drugs 0.000 claims description 4
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229940068968 polysorbate 80 Drugs 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 3
- 230000003319 supportive effect Effects 0.000 claims description 3
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 abstract description 29
- 241001148470 aerobic bacillus Species 0.000 abstract description 5
- 239000001963 growth medium Substances 0.000 description 78
- 210000001519 tissue Anatomy 0.000 description 40
- 238000011084 recovery Methods 0.000 description 38
- 108010076119 Caseins Proteins 0.000 description 33
- 102000011632 Caseins Human genes 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 26
- 239000006150 trypticase soy agar Substances 0.000 description 25
- 239000000523 sample Substances 0.000 description 24
- 230000036512 infertility Effects 0.000 description 21
- 238000012360 testing method Methods 0.000 description 18
- 229920001213 Polysorbate 20 Polymers 0.000 description 17
- -1 e.g. Substances 0.000 description 17
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 17
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 17
- 229940068977 polysorbate 20 Drugs 0.000 description 15
- 239000008057 potassium phosphate buffer Substances 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 14
- 239000002609 medium Substances 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- 239000007259 schaedler broth Substances 0.000 description 12
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- 239000001974 tryptic soy broth Substances 0.000 description 11
- 108010050327 trypticase-soy broth Proteins 0.000 description 11
- 241000186427 Cutibacterium acnes Species 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 235000014469 Bacillus subtilis Nutrition 0.000 description 9
- 241001430258 Methylobacterium radiotolerans Species 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 9
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 9
- 235000019796 monopotassium phosphate Nutrition 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 241000228150 Penicillium chrysogenum Species 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 7
- 239000007330 chocolate agar Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241000191949 Dermacoccus nishinomiyaensis Species 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 241000186245 Corynebacterium xerosis Species 0.000 description 5
- 241000187216 Streptomyces halstedii Species 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 5
- 235000019797 dipotassium phosphate Nutrition 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000008247 solid mixture Substances 0.000 description 5
- 241001331781 Aspergillus brasiliensis Species 0.000 description 4
- 241001225321 Aspergillus fumigatus Species 0.000 description 4
- 241001328122 Bacillus clausii Species 0.000 description 4
- 241000194108 Bacillus licheniformis Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 241001247311 Kocuria rhizophila Species 0.000 description 4
- 241000191938 Micrococcus luteus Species 0.000 description 4
- 241000611786 Paenibacillus glucanolyticus Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 241000190103 Setosphaeria rostrata Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 241000191963 Staphylococcus epidermidis Species 0.000 description 4
- 241000192087 Staphylococcus hominis Species 0.000 description 4
- 241000193996 Streptococcus pyogenes Species 0.000 description 4
- 239000003708 ampul Substances 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 4
- 229940055019 propionibacterium acne Drugs 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 241001661600 Bacillus idriensis Species 0.000 description 3
- 241000193470 Clostridium sporogenes Species 0.000 description 3
- 241001518263 Corynebacterium tuberculostearicum Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000006161 blood agar Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 210000005000 reproductive tract Anatomy 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000672916 Sphingomonas japonica Species 0.000 description 2
- 240000007267 Stephania hernandifolia Species 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- OQWBAXBVBGNSPW-MBJXGIAVSA-N (2s,3r,4s,5r,6r)-2-[(6-chloro-1h-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC(Cl)=CC=C12 OQWBAXBVBGNSPW-MBJXGIAVSA-N 0.000 description 1
- PKDBCJSWQUOKDO-UHFFFAOYSA-M 2,3,5-triphenyltetrazolium chloride Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 PKDBCJSWQUOKDO-UHFFFAOYSA-M 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 241001135518 Acinetobacter lwoffii Species 0.000 description 1
- 244000303769 Amaranthus cruentus Species 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000736131 Sphingomonas Species 0.000 description 1
- 241001147736 Staphylococcus capitis Species 0.000 description 1
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 1
- 241000192086 Staphylococcus warneri Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- 238000011213 bioburden testing Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000012504 compendial method Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000007518 monoprotic acids Chemical class 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940037649 staphylococcus haemolyticus Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461983675P | 2014-04-24 | 2014-04-24 | |
| US61/983,675 | 2014-04-24 | ||
| PCT/US2015/027652 WO2015164827A1 (en) | 2014-04-24 | 2015-04-24 | Microbiological growth media and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2946758A1 CA2946758A1 (en) | 2015-10-29 |
| CA2946758C true CA2946758C (en) | 2022-08-30 |
Family
ID=54333323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2946758A Active CA2946758C (en) | 2014-04-24 | 2015-04-24 | Microbiological growth media and methods of using the same |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10793823B2 (enExample) |
| EP (1) | EP3134511A4 (enExample) |
| JP (3) | JP7084719B2 (enExample) |
| KR (1) | KR20170007312A (enExample) |
| CN (1) | CN106459892A (enExample) |
| AU (3) | AU2015249274B2 (enExample) |
| BR (1) | BR112016024635A2 (enExample) |
| CA (1) | CA2946758C (enExample) |
| HK (1) | HK1232252A1 (enExample) |
| MX (2) | MX383963B (enExample) |
| SG (2) | SG11201608859PA (enExample) |
| WO (1) | WO2015164827A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016024635A2 (pt) | 2014-04-24 | 2017-08-15 | Rapid Micro Biosystems Inc | meios de crescimento microbiológico e métodos de uso do mesmo |
| CN109019867A (zh) * | 2018-05-20 | 2018-12-18 | 安信达环保科技（宁波）有限公司 | 一种氨氮去除菌缓释剂、及其制备方法和应用 |
| KR102165688B1 (ko) | 2020-04-03 | 2020-10-14 | 주식회사 퀀타매트릭스 | 그람 양성균 배양용 배양액 |
| US20230131415A1 (en) | 2020-04-15 | 2023-04-27 | Rapid Micro Biosystems, Inc. | Attenuated-background microbiological nutrient media and methods of using the same |
| KR102334454B1 (ko) | 2020-05-29 | 2021-12-03 | 코스맥스 주식회사 | 코리네박테리움 투베르쿨로스테아리쿰 균주 및 그의 피부 상태 개선 용도 |
| CN113430246B (zh) * | 2021-06-10 | 2023-06-20 | 佛山市海天(宿迁)调味食品有限公司 | 一种用于蚝油灌装空间的空气微生物快速检测方法 |
| CN113736717B (zh) * | 2021-11-03 | 2022-02-11 | 广东省科学院生态环境与土壤研究所 | 一株具有脱氮功能和缺氧抗逆性的甲烷氧化菌及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5891709A (en) * | 1992-07-13 | 1999-04-06 | The United States Of America As Represented By The Secretary Of The Agriculture | Campy-Cefex selective and differential medium for campylobacter |
| WO2003045459A1 (en) * | 2001-11-30 | 2003-06-05 | UNIVERSITé LAVAL | Milk protein biofilm and uses thereof |
| JP2004208640A (ja) | 2003-01-07 | 2004-07-29 | Rengo Co Ltd | 無細胞系タンパク質合成用酵母抽出液およびその調製方法、ならびにそれを用いた無細胞系タンパク質合成方法 |
| WO2005028626A2 (en) * | 2003-09-18 | 2005-03-31 | Raven Biotechnologies, Inc. | Cell culture media |
| WO2005064016A1 (ja) | 2003-12-26 | 2005-07-14 | Prima Meat Packers, Ltd. | 微生物の多重検出方法 |
| US8257964B2 (en) | 2006-01-04 | 2012-09-04 | Cell ASIC | Microwell cell-culture device and fabrication method |
| CA2623408C (en) | 2005-09-26 | 2014-04-01 | Rapid Micro Biosystems, Inc. | Cassette containing growth medium |
| US8066986B2 (en) | 2007-02-01 | 2011-11-29 | Master Supplements, Inc. | Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms |
| PT2427567E (pt) | 2009-05-04 | 2015-06-25 | Novartis Ag | Microensaio rápido de esterilidade |
| JP2011001352A (ja) | 2009-05-19 | 2011-01-06 | Adeka Clean Aid Co Ltd | ナイシンの殺菌上有効な使用方法 |
| EP2585189A2 (en) | 2010-06-23 | 2013-05-01 | Stobbe Tech A/s | Biopharmaceutical process apparatuses assembled into a column |
| JP2012217440A (ja) | 2011-04-14 | 2012-11-12 | Nissui Pharm Co Ltd | 袋状微生物検出用容器 |
| WO2013070730A2 (en) | 2011-11-07 | 2013-05-16 | Rapid Micro Biosystems, Inc. | Cassette for sterility testing |
| CN107345204B (zh) | 2011-12-03 | 2021-02-12 | Emd密理博公司 | 用于微流体细胞培养的微型培育系统和方法 |
| MX375939B (es) | 2012-04-16 | 2025-03-07 | Rapid Micro Biosystems Inc | Dispositivo para cultivar celulas. |
| US9238789B2 (en) | 2012-07-21 | 2016-01-19 | Therapeutic Proteins International, LLC | Baffled single use bioreactor |
| FR2997091B1 (fr) | 2012-10-22 | 2016-05-06 | Fond Mediterranee Infection | Utilisation d'un compose antioxydant pour la culture de bacteries sensibles a la tension en oxygene |
| BR112016024635A2 (pt) | 2014-04-24 | 2017-08-15 | Rapid Micro Biosystems Inc | meios de crescimento microbiológico e métodos de uso do mesmo |
-
2015
- 2015-04-24 BR BR112016024635A patent/BR112016024635A2/pt not_active Application Discontinuation
- 2015-04-24 WO PCT/US2015/027652 patent/WO2015164827A1/en not_active Ceased
- 2015-04-24 CA CA2946758A patent/CA2946758C/en active Active
- 2015-04-24 JP JP2017507933A patent/JP7084719B2/ja active Active
- 2015-04-24 MX MX2016013995A patent/MX383963B/es unknown
- 2015-04-24 CN CN201580034049.1A patent/CN106459892A/zh active Pending
- 2015-04-24 US US15/305,789 patent/US10793823B2/en active Active
- 2015-04-24 HK HK17105764.4A patent/HK1232252A1/zh unknown
- 2015-04-24 SG SG11201608859PA patent/SG11201608859PA/en unknown
- 2015-04-24 EP EP15782801.3A patent/EP3134511A4/en active Pending
- 2015-04-24 SG SG10201809259SA patent/SG10201809259SA/en unknown
- 2015-04-24 KR KR1020167032666A patent/KR20170007312A/ko not_active Ceased
- 2015-04-24 AU AU2015249274A patent/AU2015249274B2/en active Active
-
2016
- 2016-10-24 MX MX2020011318A patent/MX2020011318A/es unknown
-
2020
- 2020-10-05 US US17/063,108 patent/US11732237B2/en active Active
-
2021
- 2021-07-02 JP JP2021110510A patent/JP2021168668A/ja active Pending
- 2021-10-22 AU AU2021254655A patent/AU2021254655B2/en active Active
-
2023
- 2023-06-13 US US18/333,957 patent/US12359161B2/en active Active
-
2024
- 2024-03-14 AU AU2024201706A patent/AU2024201706A1/en active Pending
- 2024-06-11 JP JP2024094078A patent/JP2024116294A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HK1232252A1 (zh) | 2018-01-05 |
| US10793823B2 (en) | 2020-10-06 |
| KR20170007312A (ko) | 2017-01-18 |
| US20210269764A1 (en) | 2021-09-02 |
| SG10201809259SA (en) | 2018-11-29 |
| WO2015164827A1 (en) | 2015-10-29 |
| US11732237B2 (en) | 2023-08-22 |
| JP7084719B2 (ja) | 2022-06-15 |
| AU2015249274A1 (en) | 2016-12-08 |
| JP2024116294A (ja) | 2024-08-27 |
| BR112016024635A2 (pt) | 2017-08-15 |
| AU2015249274B2 (en) | 2021-07-22 |
| AU2021254655A1 (en) | 2021-11-18 |
| EP3134511A4 (en) | 2017-12-06 |
| US20230323283A1 (en) | 2023-10-12 |
| AU2021254655B2 (en) | 2023-12-14 |
| SG11201608859PA (en) | 2016-11-29 |
| JP2021168668A (ja) | 2021-10-28 |
| US12359161B2 (en) | 2025-07-15 |
| CA2946758A1 (en) | 2015-10-29 |
| EP3134511A1 (en) | 2017-03-01 |
| JP2017513532A (ja) | 2017-06-01 |
| CN106459892A (zh) | 2017-02-22 |
| MX2020011318A (es) | 2020-12-07 |
| US20170044486A1 (en) | 2017-02-16 |
| MX383963B (es) | 2025-03-14 |
| MX2016013995A (es) | 2017-08-22 |
| AU2024201706A1 (en) | 2024-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021254655B2 (en) | Microbiological growth media and methods of using the same | |
| Ananthanarayan | Ananthanarayan and Paniker's textbook of microbiology | |
| Darmawati et al. | Pathogenicity scoring system for selection of bacterial consortium formulated as bioremediation agent of Hospital Wastewater in central Java | |
| US11708558B2 (en) | Liquid sporulation method and sporulation broth | |
| JP6975701B2 (ja) | 枯草菌の単離方法、その枯草菌、枯草菌を含む微生物製剤、枯草菌単離用培地セット | |
| CN110205355A (zh) | 一种微生物高灵敏检测培养基及其制备方法和应用 | |
| CN101423863A (zh) | 一种化妆品中链球菌的检验方法 | |
| Ogodo et al. | Principles of applied microbiology and biotechnology: Technique for the screening of antimicrobial herbs | |
| Peekate et al. | Use of chloramphenicol in the differential enumeration of greenish pigment producing Pseudomonas | |
| CN106086159B (zh) | 一种能够同时检测两种粪便污染指示菌的酶底物培养基及其应用 | |
| CN105463056A (zh) | 白色念珠菌快速培养并显色的培养基及检测方法 | |
| CN104419653B (zh) | 一种分枝杆菌增菌液及其制备方法及应用 | |
| CN110317852A (zh) | 一种用于检测细胞制品中微生物的培养基及其制备方法和应用 | |
| CN100526472C (zh) | 小牛血清“双抗”培养基 | |
| CN101086008A (zh) | 微生物检测质量控制标准物质及其制备方法 | |
| Iduh et al. | Antimicrobial Activities of Sokoto Prepared Black Soap (Sabulun Salo) on Clinical Isolates of Candida albicans, Staphylococcus aureus and Escherichia coli. | |
| Rahman et al. | Bacteriological assessment of common fly (Musca domestica) as a potential carrier for public health epidemics | |
| CN106939329B (zh) | 一种用于检测霉菌性阴道炎的培养液、试剂盒及检测方法 | |
| CN104651250A (zh) | 一种ps琼脂培养基及其应用 | |
| WO2011139285A1 (en) | Method and medium for detecting the presence or absence of methicillin resistant staphylococcus aureus (mrsa) in a test sample | |
| Asma’U et al. | Viability of Clinical Staphylococcus aureus and Staphylococcus aureus ATCC 25923 Under Different Preservation Methods | |
| UTRITI et al. | Study of the electrical properties of Micrococcus lysodeikticus protoplasts showed that removal of the bacterial wall decreases the dielectric constant by two orders of magnitude, Likewise, removal of the wall reduces the effective, homogeneous conductivity of the organism in 2 M sucrose from 0.045 mho/m to. less than 0.001 mho/m. It was concluded that the cell wall had the dominant effect on the dielectric properties of bacteria. 18 | |
| Sebata | The development of peptone and yeast extract as microbiological culture media components | |
| Padhy | PHARMACEUTICAL MICROBIOLOGY (BP303T) UNIT-I | |
| CN105524853A (zh) | 一种ps琼脂培养基及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20200401 |
|
| EEER | Examination request |
Effective date: 20200401 |